Individual risk management strategy and potential therapeutic options for the COVID-19 pandemic

Clin Immunol. 2020 Jun;215:108409. doi: 10.1016/j.clim.2020.108409. Epub 2020 Apr 7.

Abstract

It is an ugly fact that a significant amount of the world's population will contract SARS-CoV-II infection with the current spreading. While a specific treatment is not yet coming soon, individual risk assessment and management strategies are crucial. The individual preventive and protective measures drive the personal risk of getting the disease. Among the virus-contracted hosts, their different metabolic status, as determined by their diet, nutrition, age, sex, medical conditions, lifestyle, and environmental factors, govern the personal fate toward different clinical severity of COVID-19, from asymptomatic, mild, moderate, to death. The careful individual assessment for the possible dietary, nutritional, medical, lifestyle, and environmental risks, together with the proper relevant risk management strategies, is the sensible way to deal with the pandemic of SARS-CoV-II.

Keywords: Antiviral medication; COVID-19; Diet; Herbs; Lifestyle; Nutrition; SARS-CoV-II; Smoking.

Publication types

  • Review

MeSH terms

  • Age Factors
  • Antiviral Agents / therapeutic use
  • Betacoronavirus / drug effects
  • Betacoronavirus / genetics
  • Betacoronavirus / pathogenicity*
  • COVID-19
  • Communicable Disease Control
  • Coronavirus Infections / epidemiology*
  • Coronavirus Infections / metabolism
  • Coronavirus Infections / prevention & control
  • Coronavirus Infections / therapy*
  • Diet / methods
  • Female
  • Gastrointestinal Microbiome / immunology
  • Humans
  • Hygiene / education
  • Immunization, Passive / methods
  • Life Style
  • Male
  • Pandemics* / prevention & control
  • Pneumonia, Viral / epidemiology*
  • Pneumonia, Viral / metabolism
  • Pneumonia, Viral / prevention & control
  • Pneumonia, Viral / therapy*
  • Precision Medicine / methods
  • Risk Management / methods*
  • SARS-CoV-2
  • Severity of Illness Index
  • Sex Factors
  • Smoking / physiopathology

Substances

  • Antiviral Agents

Supplementary concepts

  • COVID-19 serotherapy